EPAS1 抗体 (AA 535-631)
-
- 抗原 See all EPAS1 抗体
- EPAS1 (Endothelial PAS Domain Protein 1 (EPAS1))
-
抗原表位
- AA 535-631
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This EPAS1 antibody is un-conjugated
-
应用范围
- Western Blotting (WB), ELISA, Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- 原理
- Mouse monoclonal antibody raised against partial recombinant EPAS1.
- 特异性
- This antibody is specific to HIF-2 alpha and does not cross-react with HIF-1 alpha.
- 交叉反应
- 人, 小鼠, 大鼠
- 免疫原
- Recombinant protein corresponding to amino acids 535-631 of human EPAS1.
- 克隆位点
- Ep190b
- 亚型
- IgG1
- Top Product
- Discover our top product EPAS1 Primary Antibody
-
-
- 应用备注
-
ELISA (1:1000)
Flow Cytometry (1 μg/mL)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (1:150-1:300)
Western Blot (1:500)
The optimal working dilution should be determined by the end user. - 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- In PBS (0.09 % sodium azide)
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- -20 °C,-80 °C
- 储存方法
-
Store at -20°C or -80°C.
Aliquot to avoid repeated freezing and thawing.
-
-
Cyr61/CCN1 and CTGF/CCN2 mediate the proangiogenic activity of VHL-mutant renal carcinoma cells." in: Carcinogenesis, Vol. 29, Issue 4, pp. 696-703, (2008) (PubMed).
: "Expression of hypoxia-inducible factor-1alpha and its relationship to tumour angiogenesis and cell proliferation in cartilage tumours." in: The Journal of bone and joint surgery. British volume, Vol. 90, Issue 3, pp. 364-70, (2008) (PubMed).
: "Involvement of hypoxia-inducible transcription factors in polycystic kidney disease." in: The American journal of pathology, Vol. 170, Issue 3, pp. 830-42, (2007) (PubMed).
: "Targeting the loss of the von Hippel-Lindau tumor suppressor gene in renal cell carcinoma cells." in: Cancer research, Vol. 67, Issue 12, pp. 5896-905, (2007) (PubMed).
: "
-
Cyr61/CCN1 and CTGF/CCN2 mediate the proangiogenic activity of VHL-mutant renal carcinoma cells." in: Carcinogenesis, Vol. 29, Issue 4, pp. 696-703, (2008) (PubMed).
-
- 抗原
- EPAS1 (Endothelial PAS Domain Protein 1 (EPAS1))
- 别名
- HIF2A / HIF2 alpha (EPAS1 产品)
- 别名
- EPAS1 antibody, ECYT4 antibody, HIF2A antibody, HLF antibody, MOP2 antibody, PASD2 antibody, bHLHe73 antibody, HIF-2alpha antibody, HRF antibody, Hif2a antibody, bhlhe73 antibody, ecyt4 antibody, hif2 antibody, hif2a antibody, hif2alpha antibody, hlf antibody, mop2 antibody, pasd2 antibody, EPAS antibody, EPAS-1 antibody, endothelial PAS domain protein 1 antibody, endothelial PAS domain protein 1 L homeolog antibody, EPAS1 antibody, epas1 antibody, Epas1 antibody, epas1.L antibody
- 基因ID
- 2034
- 途径
- Signaling Events mediated by VEGFR1 and VEGFR2, Warburg Effect
-